Green LifeScience Co

Green LifeScience Co Liabilities

The The Liabilities of Green LifeScience Co (114450.KQ) as of Oct 21, 2026 is 16.58 B KRW. In the previous year, The Liabilities was 9.22 B KRW — a change of 79.70% (higher).

Liabilities

16.58 BKRW

YoY

79.70%

Last updated:

In 2025, Green LifeScience Co's total liabilities amounted to 16.58 B KRW, a 79.70% difference from the 9.22 B KRW total liabilities in the previous year.

The Green LifeScience Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
10.26 B KRW
Jan 1, 2019
11.54 B KRW
Jan 1, 2020
11.48 B KRW
Jan 1, 2021
15.68 B KRW
Jan 1, 2022
9.79 B KRW
Jan 1, 2023
7.87 B KRW
Jan 1, 2024
9.22 B KRW
Jan 1, 2025
16.58 B KRW
The Green LifeScience Co Liabilities history
YEARLiabilitiesYoY
16.58 BKRW+79.70%
9.22 BKRW+17.14%
7.87 BKRW-19.59%
9.79 BKRW-37.54%
15.68 BKRW+36.63%
11.48 BKRW-0.53%
11.54 BKRW+12.43%
10.26 BKRW-5.62%
10.87 BKRW-29.38%
15.39 BKRW+50.15%
10.25 BKRW-31.21%
14.90 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green LifeScience Co Stock analysis

What does Green LifeScience Co do? Green LifeScience Co Ltd produces and sells pharmaceutical and agricultural raw materials and intermediates, including AMZ for crop protection, TAZD as a herbicide intermediate, D003M and T003M for artificial marble additives, and PM04 as a pharmaceutical intermediate. The company distributes its products domestically and to international markets such as Japan, the United States, and Europe, where customers purchase these materials for agricultural and pharmaceutical applications. The firm also offers antibiotics as part of its product portfolio, targeting both domestic and overseas buyers seeking specialized chemical compounds. Green LifeScience Co Ltd generates revenue through the sale of its chemical products to customers in the agricultural and pharmaceutical sectors, with key markets including Japan, the United States, and European countries. The company’s product line caters to the needs of manufacturers requiring raw materials for crop protection, herbicides, and pharmaceutical production. Its domestic and international distribution channels support consistent sales across these segments, leveraging established relationships with buyers in the chemical supply chain. The company's offerings include specific chemical compounds like AMZ, TAZD, D003M, T003M, and PM04, which are sold to customers who integrate them into larger production processes. These products are used in the creation of crop protection materials, herbicides, artificial marble, and pharmaceuticals, serving both local and global markets. Antibiotics are also part of the sales mix, contributing to the firm’s revenue from chemical intermediates and raw materials. Green LifeScience Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Green LifeScience Co's Liabilities

Green LifeScience Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Green LifeScience Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Green LifeScience Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Green LifeScience Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Green LifeScience Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Green LifeScience Co stock

The Liabilities of Green LifeScience Co is 16.58 B KRW in 2025.

The Liabilities of Green LifeScience Co changed from 9.22 B KRW to 16.58 B KRW, representing a 79.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Green LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Green LifeScience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Green LifeScience Co

All Key Metrics — Green LifeScience Co